Company
United StatesPublic company, NASDAQ: TNDMTandem Diabetes Care, Inc. (NASDAQ: TNDM), San Diego, CA – FDA Inspections
Inspection records and compliance data for Tandem Diabetes Care, Inc. in San Diego, California. 5 FDA inspections on record, 2 Form 483s, last inspected March 23, 2023. Publicly traded as NASDAQ: TNDM.
Company Profile
This profile covers Tandem Diabetes Care, Inc. based in San Diego, California, United States.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 4
- NAI
- 1
- Form 483s
- 2
- Warning letters
- 0
First inspected December 23, 2014. Last inspected March 23, 2023.
Most cited issue areas
- Lack of or inadequate procedures2 inspections
- Design Validation - Risk analysis not performed/inadequate1 inspection
- Equipment design and installation1 inspection
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 23, 2023 | VAI | Medical Devices & Rad Health · Compliance: Devices | 1200609 |
| October 15, 2021 | VAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 1155101 |
| June 19, 2018 | NAI | Medical Devices & Rad Health · Bioresearch Monitoring | 1057284 |
| November 18, 2016 | VAI | Medical Devices & Rad Health · Compliance: Devices | 998792 |
| December 23, 2014 | VAI | Medical Devices & Rad Health · Compliance: Devices | 910518 |
FDA documents
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Tandem Diabetes Care, Inc.
Stock ticker
TNDM
Exchange
NASDAQ
Share price
$17.51
Market cap
$1.2B
Price as of
November 13, 2026
FEI Number
3007981285
Address
11075 Roselle St, San Diego, California 92121, United States
Country
United States
ID: 55c8bf38-f959-46dd-8954-5ac3480bea3e